Pinsent Masons appoints prominent Life Sciences partner in London

Gareth, who joins from CMS, is a market-leading pharma patent and medicines regulatory specialist, with significant experience in all areas of contentious and non-contentious intellectual property (IP) law. He has acted in many landmark UK IP trials concerning patent entitlement, pharmaceutical and biotechnology patent validity and infringement, SPCs and the interpretation of IP licences.

Joining the firm’s London office, he brings with him a team of five lawyers who will all work closely with partner Catherine Drew to expand the firm’s medicine regulatory litigation offering.

With a PhD in molecular biology, Gareth is passionate about the life sciences sector and joins a full-service team where many hold relevant scientific qualifications and degrees, including in genetics, medicinal chemistry, human biology, and biochemistry.

Head of IP & Life Sciences Clare Tunstall said:

"The needs of our life sciences clients are continuously evolving, and we need to ensure that we can support them across all business-critical areas. The appointment of Gareth will significantly bolster our ability to service our international client base, particularly in respect of medicine regulatory and patent litigation work where we are seeing a growing demand across our European business".

Head of technology, science & industry Florian von Baum added:

"Gareth’s reputation precedes him; he is a market leading international practitioner with deep sector knowledge and will add invaluable strength to our team. His appointment bolsters key proficiencies across our multinational team.”

Gareth’s hire follows the recent appointment of life sciences partners Gina Bicknell in London and Machteld Hiemstra in Amsterdam.